Science and Technology Science and Technology

Why Novo Nordisk A/S (NVO) Is the Best Blue Chip Stock to Buy Under $100?


Published on 2025-01-29 17:21:17 - MSN
  Print publication without navigation

  • We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best blue chip stocks to buy under $100.

The article from MSN Money discusses why Novo Nordisk A/S (NVO) is considered the best blue-chip stock to buy under $100. It highlights several key points: Novo Nordisk, a Danish multinational pharmaceutical company, is renowned for its focus on diabetes care, obesity, and other chronic diseases. The company's stock has shown consistent growth, supported by its strong product pipeline, particularly with drugs like Ozempic and Wegovy, which have seen significant market success. The article points out that despite its high valuation, Novo Nordisk's forward-looking earnings growth, robust financial health, and a history of increasing dividends make it an attractive investment. Additionally, the company's strategic expansion into new markets and its commitment to research and development further solidify its position as a stable and promising investment for those looking at blue-chip stocks within this price range.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/why-novo-nordisk-a-s-nvo-is-the-best-blue-chip-stock-to-buy-under-100/ar-AA1y52bJ ]